The Harvard Drug Group LLC is recalling one lot of Memantine Hydrochloride Extended-Release (7 mg capsules) because the medication failed to meet dissolution specifications during testing. This prescription medication, used to treat symptoms of Alzheimer's disease, was packaged under the Major Pharmaceuticals brand in 100-count blister packs. No injuries or adverse incidents have been reported to date regarding this specific lot.
A dissolution failure means the medication may not release into the body at the correct rate, which could potentially reduce the drug's effectiveness in managing symptoms or lead to unexpected blood levels of the medication.
You have 2 options:
Packaged and Distributed by: Major Pharmaceuticals; 10 x 10 blister packs; Rx only.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.